Apalutamide Plus Androgen Deprivation: New Option for High-Risk Prostate Cancer Patients
Senior Editor, Health — Dr. Priya Deshmukh A new standard for high-risk localized prostate cancer has emerged this week: apalutamide, when combined with androgen deprivation therapy (ADT) before surgery, significantly ... Read More